home | search the site | e-mail us

Adam Geneva logo

 Welcome to Adam / Announcements January 2015


A.D.A.M. seeks to appoint an
RF Engineer / Accelerator Physicist
The successful candidate has experience in analog and digital circuit design, modelling and simulation for RF applications. His major role will be the development of the LLRF system for feedback controls (frequency, amplitude and phase) and synchronization of different accelerating units composing the proton linear accelerator.
Work in radiation controlled area is foreseen.
More information and requirements, click here

A.D.A.M. seeks to appoint
One experimental physicist (limited duration)
The successful candidate is expected to work on simulations of the accelerating structure and of the interaction of particles lost by the beam with the surrounding material; in particular he/she will be responsible for the evaluation of the radiation level produced outside the accelerating structures in order to optimize the needed shielding.
More information and requirements, click here

Who we are

Established on 20th December 2007, ADAM SA was founded  to promote scientific know-how and innovations in medical technology for cancer therapy.

ADAM SA, headquartered in Geneva, Switzerland, aims to be a world’s leading centre of excellence for research, engineering and industrialization of linear accelerators and detectors for medical applications.

ADAM SA employs high-profile experts and specialists in physics and engineering and numbers important collaborations with hospitals, research centres and other world leading companies.

 Research Objectives

ADAM research activity is mainly focused on the construction and testing of linear accelerators (linacs) for medical purposes. ADAM has designed, built and tested the first unit of a linear accelerator for proton therapy and a small accelerator for IORT. An ancillary product engineered by the company is also a dosimeter, for real-time monitoring of the exact dose delivered to the patient during a radiotherapy treatment.

 News & Events